In colorectal cancer, analysis on the impact of RCN3 on patients’ prognosis showed that the expression level of RCN3 is an independent risk factor for a poor prognosis and response to chemotherapy (Ma et al., 2022). This evidence concerns the gene RCN3 and colorectal cancer.